Sarasin & Partners LLP Amgen Inc Transaction History

Sarasin & Partners LLP

$10.2 Billion
Q1 2024

A detailed history of Sarasin & Partners LLP transactions in Amgen Inc stock. As of the latest transaction made, Sarasin & Partners LLP holds 1,141,393 shares of AMGN stock, worth $357 Million. This represents 3.2% of its overall portfolio holdings.

Number of Shares

1,141,393

Previous 1,147,693 0.55%

Holding current value

$357 Million

Previous $331 Million 1.83%

% of portfolio

3.2%

Previous 3.63%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 12, 2024	SELL	$268.87 - $324.56 $1.69 Million - $2.04 Million	-6,300 Reduced 0.55%	1,141,393 $325 Million
Q4 2023 Jan 09, 2024	SELL	$255.7 - $288.46 $9.24 Million - $10.4 Million	-36,118 Reduced 3.05%	1,147,693 $331 Million
Q3 2023 Oct 05, 2023	SELL	$218.65 - $271.46 $13 Million - $16.1 Million	-59,287 Reduced 4.77%	1,183,811 $318 Million
Q2 2023 Jul 10, 2023	BUY	$214.27 - $253.37 $28.8 Million - $34 Million	134,366 Added 12.12%	1,243,098 $276 Million
Q1 2023 May 05, 2023	SELL	$225.79 - $275.2 $59.8 Million - $72.8 Million	-264,681 Reduced 19.27%	1,108,732 $268 Million

Q1 2023 Apr 27, 2023	BUY	$225.79 - $275.2 $91.5 Million - $112 Million	405,440 Added 41.89%	1,373,413 $332 Million
Q4 2022 Jan 30, 2023	SELL	$229.03 - $291.01 $5.68 Million - $7.21 Million	-24,789 Reduced 2.5%	967,973 $254 Million
Q3 2022 Oct 18, 2022	SELL	$224.46 - $253.15 $73.2 Million - $82.6 Million	-326,209 Reduced 24.73%	992,762 $224 Million
Q2 2022 Jul 13, 2022	SELL	$230.71 - $256.74 $10.3 Million - $11.5 Million	-44,636 Reduced 3.27%	1,318,971 $321 Million
Q1 2022 Apr 11, 2022	SELL	$219.27 - $242.57 $1.28 Million - $1.41 Million	-5,828 Reduced 0.43%	1,363,607 $330 Million
Q4 2021 Jan 19, 2022	BUY	$198.88 - $227.6 $32.9 Million - $37.7 Million	165,636 Added 13.76%	1,369,435 $308 Million
Q3 2021 Oct 22, 2021	BUY	$212.27 - $248.7 $8.6 Million - $10.1 Million	40,507 Added 3.48%	1,203,799 $256 Million
Q2 2021 Jul 13, 2021	BUY	$233.58 - $259.14 $15.1 Million - $16.7 Million	64,592 Added 5.88%	1,163,292 $284 Million
Q1 2021 Apr 29, 2021	BUY	$221.91 - $258.6 $9.63 Million - $11.2 Million	43,409 Added 4.11%	1,098,700 $273 Million
Q4 2020 Jan 19, 2021	BUY	$216.38 - $257.67 $21.6 Million - $25.8 Million	99,942 Added 10.46%	1,055,291 $243 Million
Q3 2020 Nov 09, 2020	SELL	$234.65 - $260.95 $2.54 Million - $2.82 Million	-10,816 Reduced 1.12%	955,349 $243 Million
Q2 2020 Jul 17, 2020	SELL	$197.81 - $242.74 $8.45 Million - $10.4 Million	-42,703 Reduced 4.23%	966,165 $228 Million
Q1 2020 Apr 30, 2020	SELL	$182.24 - $241.7 $12.2 Million - $16.2 Million	-67,122 Reduced 6.24%	1,008,868 $205 Million
Q4 2019 Feb 12, 2020	BUY	$189.21 - $243.2 $883,043 - $1.14 Million	4,667 Added 0.44%	1,075,990 $259 Million
Q3 2019 Nov 08, 2019	BUY	$174.11 - $208.62 $18.5 Million - $22.2 Million	106,302 Added 11.02%	1,071,323 $207 Million
Q2 2019 Jul 18, 2019	BUY	$166.7 - $195.41 $7.5 Million - $8.79 Million	44,977 Added 4.89%	965,021 $178 Million
Q1 2019 May 13, 2019	BUY	$180.87 - $203.88 $10.3 Million - $11.7 Million	57,152 Added 6.62%	920,044 $175 Million
Q4 2018 Feb 12, 2019	BUY	$178.4 - $208.25 $1.24 Million - $1.45 Million	6,960 Added 0.81%	862,892 $168 Million
Q3 2018 Nov 09, 2018	SELL	$185.29 - $208.89 $22.2 Million - $25.1 Million	-120,067 Reduced 12.3%	855,932 $177 Million
Q2 2018 Aug 07, 2018	BUY	$166.05 - $186.51 $1.27 Million - $1.43 Million	7,660 Added 0.79%	975,999 $180 Million
Q1 2018 May 01, 2018	BUY	$169.43 - $198.0 $8.37 Million - $9.79 Million	49,426 Added 5.38%	968,339 $165 Million
Q4 2017 Feb 06, 2018	SELL	$168.79 - $188.59 $1.03 Million - $1.15 Million	-6,104 Reduced 0.66%	918,913 $160 Million
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $155 Million - $177 Million	925,017	925,017 $172 Million

Others Institutions Holding AMGN

# of Institutions

2,930

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $167B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sarasin & Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Sarasin & Partners LLP with notifications on news.

Account

Sarasin & Partners LLP Amgen Inc Transaction History